Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Han-Na Kang"'
Autor:
Yongmin Cho, Moon Nyeo Park, Min Choi, Tarun Kumar Upadhyay, Han Na Kang, Jeong Min Oh, Soonki Min, Ji-Ung Yang, Moonkyoo Kong, Seong-Gyu Ko, Md Ataur Rahman, Abdel Halim Harrath, Bonglee Kim
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundPancreatic cancer (PC), sometimes referred to as pancreatic ductal adenocarcinoma (PDAC), is a major cause of global mortality from cancer. Pancreatic cancer is a very aggressive and devastating kind of cancer, characterized by limited opti
Externí odkaz:
https://doaj.org/article/398e2b37514d4c47949a047caff24118
Autor:
Pratibha Pandey, Fahad Khan, Min Choi, Sujeet Kumar Singh, Han Na Kang, Moon Nyeo Park, Seong-Gyu Ko, Sanjeev Kumar Sahu, Rupa Mazumder, Bonglee Kim
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 164, Iss , Pp 114938- (2023)
In the current period of drug development, natural products have provided an unrivaled supply of anticancer medications. By modifying the cancer microenvironment and various signaling pathways, natural products and their derivatives and analogs play
Externí odkaz:
https://doaj.org/article/9ec6b3af718a4f6ebe1a522dfd9fb8dc
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Immune checkpoint blockage targeting PD-L1 has led to breakthroughs in cancer treatment. Although anti-PD-L1-based immunotherapy has been approved as standard therapy in various cancer types, its therapeutic efficacy in most colorectal cancers (CRC)
Externí odkaz:
https://doaj.org/article/de305839b1af45c188373a86181f8882
Autor:
Han Na Kang, Jae-Hwan Kim, A-Young Park, Jae Woo Choi, Sun Min Lim, Jinna Kim, Eun Joo Shin, Min Hee Hong, Kyoung-Ho Pyo, Mi Ran Yun, Dong Hwi Kim, Hanna Lee, Sun Och Yoon, Da Hee Kim, Young Min Park, Hyung Kwon Byeon, Inkyung Jung, Soonmyung Paik, Yoon Woo Koh, Byoung Chul Cho, Hye Ryun Kim
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background We investigated whether head and neck squamous cell carcinoma (HNSCC) patient-derived xenografts (PDXs) reaffirm patient responses to anti-cancer therapeutics. Methods Tumors from HNSCC patients were transplanted into immunodefici
Externí odkaz:
https://doaj.org/article/d789d28930c4424bb99a3602f9eb9a8f
Autor:
Han Na Kang, Soo Won Lee
Publikováno v:
Education Research Institute, Chungbuk National University. 44:125-144
Autor:
Mi Ran Yun, Hun Mi Choi, You Won Lee, Hyeong Seok Joo, Chae Won Park, Jae Woo Choi, Dong Hwi Kim, Han Na Kang, Kyoung‐Ho Pyo, Eun Joo Shin, Hyo Sup Shim, Ross A Soo, James Chih‐Hsin Yang, Sung Sook Lee, Hyun Chang, Min Hwan Kim, Min Hee Hong, Hye Ryun Kim, Byoung Chul Cho
Publikováno v:
EMBO Molecular Medicine, Vol 11, Iss 12, Pp n/a-n/a (2019)
Abstract Clinical benefit of ALK tyrosine kinase inhibitors (ALK‐TKIs) in ALK‐rearranged lung cancer has been limited by the inevitable development of acquired resistance, and bypass‐molecular resistance mechanisms remain poorly understood. We
Externí odkaz:
https://doaj.org/article/d4178ca591ff41c1b89ca89a0354a643
Autor:
Byoung Chul Cho, Soonmyung Paik, Joo Hang Kim, Yong Wha Moon, Sun Min Lim, Hye Ryun Kim, Chan Woo Kang, Han Na Kang, Mi Ran Yun, Jinyoung Sohn, Min Hwan Kim, Kang Won Jang, Hwan Kim, Sung-Moo Kim
A, Lysates from MV522 cells and GSR cells were evaluated by western blotting to determine total and phosphorylated c-MET levels from the arrays in Fig. 3A. B, MV522 cells and GSR cells were cultured in control (CTL), 0.1 µM GSK2118436 (GSK), or 2 µ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2ad08a4c1e99a8eef466e436598c93d
https://doi.org/10.1158/1535-7163.22508431
https://doi.org/10.1158/1535-7163.22508431
Autor:
Byoung Chul Cho, Joo Hang Kim, Dae Joon Kim, Soonmyung Paik, Yong Wha Moon, Sun Min Lim, Hye Ryun Kim, Han Na Kang, Mi Ran Yun, Hwan Kim, Kyoung-Ho Pyo, Sung-Moo Kim, Jinyoung Sohn, Kang Won Jang, Chan Woo Kang
Supplementary Table 2. siRNA sequences
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c43856d174d4f9d1ab474d080a0971e
https://doi.org/10.1158/1535-7163.22506099
https://doi.org/10.1158/1535-7163.22506099
Autor:
Byoung Chul Cho, Joo Hang Kim, Dae Joon Kim, Soonmyung Paik, Yong Wha Moon, Sun Min Lim, Hye Ryun Kim, Han Na Kang, Mi Ran Yun, Hwan Kim, Kyoung-Ho Pyo, Sung-Moo Kim, Jinyoung Sohn, Kang Won Jang, Chan Woo Kang
Supplementary Figure 2. Significant weight loss in LC-2/ad xenograft mice treated with vandetanib Mice bearing LC-2/ad cells were treated with vehicle only (Vehicle), dovitinib (DO 30mg/kg), dovitinib (DO 60mg/kg), or vandetanib (VA 50mg/kg) for 32da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1197869ce5a722e8ad55404101b4ef7f
https://doi.org/10.1158/1535-7163.22506111.v1
https://doi.org/10.1158/1535-7163.22506111.v1
Autor:
Byoung Chul Cho, Soonmyung Paik, Joo Hang Kim, Yong Wha Moon, Sun Min Lim, Hye Ryun Kim, Chan Woo Kang, Han Na Kang, Mi Ran Yun, Jinyoung Sohn, Min Hwan Kim, Kang Won Jang, Hwan Kim, Sung-Moo Kim
Supplementary Table S1. Sequencing primers (Sanger) Supplementary Table S2. siRNA sequences
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e87fc33f96077f3bdf2a02734cafccb
https://doi.org/10.1158/1535-7163.22508416.v1
https://doi.org/10.1158/1535-7163.22508416.v1